Analysts Are Bullish on These Healthcare Stocks: Vanda (VNDA), Abeona Therapeutics (ABEO)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vanda (VNDA – Research Report) and Abeona Therapeutics (ABEO – Research Report) with bullish sentiments.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Vanda (VNDA)
In a report released today, Olivia Brayer from Cantor Fitzgerald maintained a Buy rating on Vanda, with a price target of $11.00. The company’s shares closed last Friday at $5.76.
According to TipRanks.com, Brayer is a 3-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Vanda with a $14.13 average price target, representing a 134.7% upside. In a report issued on February 17, H.C. Wainwright also reiterated a Buy rating on the stock with a $22.00 price target.
See today’s best-performing stocks on TipRanks >>
Abeona Therapeutics (ABEO)
In a report released today, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on Abeona Therapeutics, with a price target of $28.00. The company’s shares closed last Friday at $5.26.
According to TipRanks.com, Kluska is a 5-star analyst with an average return of
Currently, the analyst consensus on Abeona Therapeutics is a Strong Buy with an average price target of $24.00.
